MetaCap

Mesoblast (MESO) News

NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.89-0.29 (-2.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MESO news summary

We found 10 recent headlines mentioning Mesoblast (MESO): 3 in the past week and 9 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, MESO is down 2.59% at $10.89. The most recent story, "Mesoblast Wins Deloitte Tech Fast 50 Leadership & Enterprise Growth Award", was published by GlobeNewswire on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Mesoblast headlines

Stocks mentioned alongside MESO

Compare MESO